OptiBiotix Health PLC
LSE:OPTI
OptiBiotix Health PLC
Cash & Cash Equivalents
OptiBiotix Health PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
OptiBiotix Health PLC
LSE:OPTI
|
Cash & Cash Equivalents
£893k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash & Cash Equivalents
$128m
|
CAGR 3-Years
161%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash & Cash Equivalents
$239.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash & Cash Equivalents
$457m
|
CAGR 3-Years
33%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash & Cash Equivalents
£442.6m
|
CAGR 3-Years
51%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash & Cash Equivalents
£42m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
See Also
What is OptiBiotix Health PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
893k
GBP
Based on the financial report for Jun 30, 2023, OptiBiotix Health PLC's Cash & Cash Equivalents amounts to 893k GBP.
What is OptiBiotix Health PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-13%
Over the last year, the Cash & Cash Equivalents growth was -41%. The average annual Cash & Cash Equivalents growth rates for OptiBiotix Health PLC have been -15% over the past three years , -13% over the past five years .